Concepedia

Publication | Open Access

Effects of Intravenously Administered Recombinant Vesicular Stomatitis Virus (VSV ΔM51 ) on Multifocal and Invasive Gliomas

DOIFull Paper Access

95

Citations

54

References

2006

Year

XueQing Lun, Donna L. Senger, Tommy Alain, Andra Oprea, Kelley A. Parato, Dave F Stojdl, Brian D. Lichty, Anthony Power, Randal N. Johnston, Mark G. Hamilton,
JNCI Journal of the National Cancer Institute

Abstract

Systemically delivered VSV(deltaM51) was an effective and safe oncolytic agent against laboratory models of multifocal and invasive malignant gliomas, the most challenging clinical manifestations of this disease.

References

YearCitations

Page 1